Visualization of gene therapy with a liver cancer-targeted adeno-associated virus 3 vector

Conclusions: The scrAAV3 vector has a strong liver cancer-targeting ability, and the ATK gene drug can be used for targeted and non-invasive monitoring of liver cancer gene therapy.

Source: Journal of Cancer - July 2, 2020 Category: Cancer & Oncology Authors: Xusheng Liu, Hanling Huang, Yan Gao, Lumeng Zhou, Jianwei Yang, Xiaohui Li, Yang Li, Haiwen Zhao, Shanchun Su, Changbin Ke, Zhijun Pei Tags: Research Paper Source Type: research